Colombo, N; Harano, K; Hudson, E; Galli, F; Antill, Y; Choi, CH; Rabaglio, M; Marmé, F; Petru, E; Lai, CH; Biagioli, E; Madrid, LF; Takehara, K; Allan, K; Lee, YC; Piovano, E; Zamagni, C; Tasca, G; Ferrero, A; Ginesta, MPB.
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
ANN ONCOL. 2023; 34: S1281-S1282.
Doi: 10.1016/j.annonc.2023.10.034
[Poster]
Web of Science
FullText
FullText_MUG